A CT scan cannot definitively diagnose Alzheimer’s disease. It does not detect the amyloid plaques or tau tangles that define Alzheimer’s at a biological level. What a CT scan can do is show physical changes in the brain, like shrinkage, and rule out other treatable conditions that mimic dementia symptoms. That makes it a useful first step in a workup, but not the final answer.
What a CT Scan Actually Shows
When doctors order a brain CT during a dementia evaluation, they’re primarily looking for other explanations for memory loss and cognitive decline. A CT scan can reveal tumors, strokes, blood clots, infections, fluid buildup in the brain, and damage to blood vessels. These are all conditions that can cause symptoms resembling Alzheimer’s but require very different treatment. In some cases, they’re reversible.
A CT scan can also show brain atrophy, which is the progressive loss of brain tissue. In a healthy brain, the ridges on the surface are thick and the fluid-filled cavities (ventricles) in the center are compact. As neurons die in Alzheimer’s, those ridges thin out, the grooves between them widen, and the ventricles expand to fill the empty space. These structural changes are visible on CT, especially in later stages of the disease.
Radiologists sometimes use a visual rating scale to assess shrinkage in the medial temporal lobe, a brain region hit early by Alzheimer’s. The scale runs from 0 (no atrophy) to 4 (severe atrophy), tracking how much the hippocampus and surrounding structures have lost volume. A score of 0 means no visible fluid surrounding the hippocampus. By scores of 2 to 4, the fluid-filled spaces have progressively enlarged and the hippocampus itself has visibly shrunk. This scoring can support a clinical suspicion of Alzheimer’s, but it doesn’t confirm it on its own.
Why CT Can’t Confirm Alzheimer’s
Alzheimer’s disease is defined by two specific protein buildups in the brain: amyloid plaques and neurofibrillary tangles made of tau protein. A CT scan measures brain structure. It measures atrophy, strokes, and physical damage. There is nothing about a CT scan that directly detects amyloid or tau. Brain shrinkage can suggest that a neurodegenerative process is underway, but many conditions cause atrophy, including normal aging, vascular dementia, frontotemporal dementia, and chronic alcohol use. A shrunken brain on a CT scan does not equal Alzheimer’s.
This distinction matters most in early stages. When someone has mild cognitive impairment or early Alzheimer’s, brain atrophy may be minimal or absent on a standard CT. The disease can be developing at the molecular level for years before enough tissue is lost to show up on structural imaging. By the time a CT scan clearly shows widespread atrophy, the disease has typically been progressing for a long time.
How CT Compares to MRI
MRI is generally more sensitive than CT for evaluating brain changes tied to cognitive impairment. It provides higher-resolution images of soft tissue, which makes it better at detecting subtle hippocampal atrophy and small vascular lesions. For this reason, MRI is the preferred imaging tool in most dementia evaluations when it’s available and the patient can tolerate it.
That said, CT has practical advantages. It costs roughly half what an MRI does, with brain MRIs typically running $1,200 to $4,000. CT scans are fast, often completed in minutes, which helps with patients who have difficulty staying still or who become anxious in enclosed spaces. CT is also an option for people who can’t undergo MRI because of pacemakers or other metal implants. In emergency settings or when MRI access is limited, CT serves as a reasonable first-line tool.
Interestingly, one study using advanced computer analysis (a technique called voxel-based morphometry) found that CT-based analysis actually detected larger areas of significant gray matter loss in Alzheimer’s patients compared to MRI-based analysis, particularly in the medial temporal lobe and surrounding regions. This suggests CT data contains more diagnostic information than is typically extracted in routine clinical reads. In everyday practice, though, standard MRI still offers the clearer picture for a radiologist evaluating atrophy by eye.
Imaging That Can Detect Alzheimer’s Directly
PET scans are the imaging tools that come closest to detecting Alzheimer’s disease itself. Amyloid PET scans use a radioactive tracer that binds to amyloid plaques in the brain, making them visible. Tau PET scans work similarly for tau tangles. Another type, FDG-PET, measures how actively different brain regions are using glucose, which reveals patterns of reduced activity characteristic of Alzheimer’s.
PET imaging has far higher sensitivity for early disease than either CT or MRI. It can detect molecular changes weeks, months, or even years before structural damage becomes visible on a CT or MRI scan. This is because PET measures biological activity at the molecular level rather than waiting for enough tissue to die that the brain physically shrinks. Some newer hybrid scanners combine PET with CT or MRI in a single session, using PET to identify early disease and CT or MRI to pinpoint exactly where in the brain it’s located.
PET scans are expensive and not yet part of routine clinical practice for everyone with memory concerns. Blood-based biomarker tests for amyloid and tau are also emerging as simpler screening options. But for now, PET remains the most direct imaging method for confirming Alzheimer’s pathology in a living person.
What to Expect if Your Doctor Orders a CT
If you or a family member is being evaluated for memory problems and the doctor orders a brain CT, it doesn’t necessarily mean they suspect Alzheimer’s. They may be starting with CT to quickly and affordably check for treatable causes of cognitive changes, such as a slow-growing tumor, a previous stroke you didn’t know about, or excess fluid pressing on the brain. The scan itself takes only a few minutes, is painless, and doesn’t require you to lie in a narrow tube the way MRI does.
If the CT is normal or shows only mild age-related changes, that doesn’t rule out Alzheimer’s. It means the brain’s overall structure looks intact, which is useful information but not the whole picture. Your doctor may then recommend an MRI for a more detailed look, cognitive testing, blood work, or in some cases a PET scan or spinal fluid analysis to check for amyloid and tau proteins directly. Diagnosing Alzheimer’s typically involves combining results from several of these tools rather than relying on any single test.